Reaction of COVID-19 vaccine makers to possible patents waiver 2021

Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021

Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver

Last update:

May 19, 2021

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/05/2021 to 30/06/2021

As of May 2021, Moderna's share price decreased by seven percent as a reaction to the U.S. support of the WTO's proposed temporary waiver of COVID-19 vaccine patents. This statistic illustrates the early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering COVID-19 vaccine patents.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021

Get in touch with us for additional information

��ƽ��